These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3998061)

  • 1. Genetic transmission of tumoral calcinosis: autosomal dominant with variable clinical expressivity.
    Lyles KW; Burkes EJ; Ellis GJ; Lucas KJ; Dolan EA; Drezner MK
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1093-6. PubMed ID: 3998061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dental lesions in tumoral calcinosis.
    Burkes EJ; Lyles KW; Dolan EA; Giammara B; Hanker J
    J Oral Pathol Med; 1991 May; 20(5):222-7. PubMed ID: 2066872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.
    Ichikawa S; Lyles KW; Econs MJ
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2420-3. PubMed ID: 15687324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of familial tumoral calcinosis in a neonate and review of the literature.
    Polykandriotis EP; Beutel FK; Horch RE; Grünert J
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):563-7. PubMed ID: 15340747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.
    Larsson T; Yu X; Davis SI; Draman MS; Mooney SD; Cullen MJ; White KE
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2424-7. PubMed ID: 15687325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial tumoral calcinosis: a forty-year follow-up on one family.
    Carmichael KD; Bynum JA; Evans EB
    J Bone Joint Surg Am; 2009 Mar; 91(3):664-71. PubMed ID: 19255228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis.
    Steinherz R; Chesney RW; Eisenstein B; Metzker A; DeLuca HF; Phelps M
    Am J Dis Child; 1985 Aug; 139(8):816-9. PubMed ID: 3839626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing.
    Shah A; Miller CJ; Nast CC; Adams MD; Truitt B; Tayek JA; Tong L; Mehtani P; Monteon F; Sedor JR; Clinkenbeard EL; White K; Mehrotra R; LaPage J; Dickson P; Adler SG; Iyengar SK
    Nephrol Dial Transplant; 2014 Dec; 29(12):2235-43. PubMed ID: 25378588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis.
    Masi L; Gozzini A; Franchi A; Campanacci D; Amedei A; Falchetti A; Franceschelli F; Marcucci G; Tanini A; Capanna R; Brandi ML
    J Bone Joint Surg Am; 2009 May; 91(5):1190-8. PubMed ID: 19411468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene.
    Ichikawa S; Imel EA; Sorenson AH; Severe R; Knudson P; Harris GJ; Shaker JL; Econs MJ
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4472-5. PubMed ID: 16940445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders.
    Frishberg Y; Topaz O; Bergman R; Behar D; Fisher D; Gordon D; Richard G; Sprecher E
    J Mol Med (Berl); 2005 Jan; 83(1):33-8. PubMed ID: 15599692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
    Garringer HJ; Fisher C; Larsson TE; Davis SI; Koller DL; Cullen MJ; Draman MS; Conlon N; Jain A; Fedarko NS; Dasgupta B; White KE
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4037-42. PubMed ID: 16868048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial tumoral calcinosis.
    Alkhatib A; Burton LE; Carachi R
    Scott Med J; 2014 Nov; 59(4):e17-20. PubMed ID: 25351424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations.
    Prince MJ; Schaeffer PC; Goldsmith RS; Chausmer AB
    Ann Intern Med; 1982 May; 96(5):586-91. PubMed ID: 6896123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Root anomalies and dentin dysplasia in autosomal recessive hyperphosphatemic familial tumoral calcinosis (HFTC).
    Vieira AR; Lee M; Vairo F; Loguercio Leite JC; Munerato MC; Visioli F; D'Ávila SR; Wang SK; Choi M; Simmer JP; Hu JC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Dec; 120(6):e235-9. PubMed ID: 26337219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumoral calcinosis and Engelmann disease.
    Thurmon TF; Jackson J
    Birth Defects Orig Artic Ser; 1976; 12(5):321-5. PubMed ID: 953237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations of serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis.
    Lyles KW; Halsey DL; Friedman NE; Lobaugh B
    J Clin Endocrinol Metab; 1988 Jul; 67(1):88-92. PubMed ID: 3379139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in
    Kışla Ekinci RM; Gürbüz F; Balcı S; Bişgin A; Taştan M; Yüksel B; Yılmaz M
    J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):94-99. PubMed ID: 30015621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
    Lammoglia JJ; Mericq V
    Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.
    Zuo QY; Cao X; Liu BY; Yan D; Xin Z; Niu XH; Li C; Deng W; Dong ZY; Yang JK
    J Endocrinol Invest; 2020 Feb; 43(2):173-183. PubMed ID: 31535357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.